Herein, we describe the therapeutic efficacy of a liver-targeted single-strand AAV8 vector as a new gene therapy treatment for CTLN1 with the potential for translation to the clinic. The AAV8-treated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback